[HTML][HTML] CAR models: next-generation CAR modifications for enhanced T-cell function
D Abate-Daga, ML Davila - Molecular Therapy-Oncolytics, 2016 - cell.com
T cells genetically targeted with a chimeric antigen receptor (CAR) to B-cell malignancies
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …
CAR models: next-generation CAR modifications for enhanced T-cell function
D Abate-Daga, ML Davila - Molecular therapy oncolytics, 2016 - pubmed.ncbi.nlm.nih.gov
T cells genetically targeted with a chimeric antigen receptor (CAR) to B-cell malignancies
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …
CAR models: next-generation CAR modifications for enhanced T-cell function
D Abate-daga, ML Davila - Molecular Therapy. Oncolytics, 2016 - search.proquest.com
T cells genetically targeted with a chimeric antigen receptor (CAR) to B-cell malignancies
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …
[HTML][HTML] CAR models: next-generation CAR modifications for enhanced T-cell function
D Abate-Daga, ML Davila - Molecular Therapy Oncolytics, 2016 - ncbi.nlm.nih.gov
T cells genetically targeted with a chimeric antigen receptor (CAR) to B-cell malignancies
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …
[引用][C] CAR models: next-generation CAR modifications for enhanced T-cell function
D Abate-Daga, ML Davila - Molecular Therapy-Oncolytics, 2016 - cir.nii.ac.jp
CAR models: next-generation CAR modifications for enhanced T-cell function | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …
[PDF][PDF] CAR models: next-generation CAR modifications for enhanced T-cell function
researchgate.net
Molecular Therapy—Oncolytics (2016) 16014 Official journal of the American Society of
Gene & Cell Therapy cross-reactivity to similar sequences of amino acids. 12 TCR ligation of …
Gene & Cell Therapy cross-reactivity to similar sequences of amino acids. 12 TCR ligation of …
CAR models: next-generation CAR modifications for enhanced T-cell function.
D Abate-Daga, ML Davila - Molecular Therapy Oncolytics, 2016 - europepmc.org
T cells genetically targeted with a chimeric antigen receptor (CAR) to B-cell malignancies
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …
[HTML][HTML] CAR models: next-generation CAR modifications for enhanced T-cell function
D Abate-Daga, ML Davila - Molecular Therapy-Oncolytics, 2016 - Elsevier
T cells genetically targeted with a chimeric antigen receptor (CAR) to B-cell malignancies
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …
have demonstrated tremendous clinical outcomes. With the proof in principle for CAR T cells …